Novo Nordisk on Friday released headline data from the Phase III REDEFINE 1 trial of its next-generation weight-loss therapy CagriSema, touting superior weight loss in people with obesity and overweight than just cagrilintide, semaglutide (marketed as Wegovy for weight loss and Ozempic for diabetes) or placebo
Individual results vary, and what works for one person may not be appropriate for another
Ready to take your transformation to the next level
They also didn't eat more when they stopped getting nicotine
People who use the appetite suppression as an opportunity to improve dietary quality, choosing nutrient-dense foods , adequate protein, and appropriate fiber, tend to see better and faster results than those who simply eat smaller portions of the same calorie-dense foods
At the same time, their well-documented effects on gut motility raise reasonable questions about digestive health, especially for individuals with IBS, a history of food poisoning, constipation, or other risk factors for microbial overgrowth